ProfileGDS4718 / 1569409_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 84% 79% 84% 86% 79% 81% 81% 84% 83% 80% 82% 77% 80% 80% 81% 78% 82% 79% 96% 82% 80% 79% 80% 86% 75% 82% 90% 85% 84% 80% 81% 86% 80% 79% 77% 86% 83% 81% 76% 80% 85% 81% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.3692384
GSM549102patient 115, normal, homogenized [OPG study]8.2368784
GSM549104patient 119, normal, homogenized [OPG study]7.7718579
GSM549108patient 138, normal, homogenized [OPG study]8.2514684
GSM549119patient 077, normal, homogenized [OPG study]8.604486
GSM549133patient 032, cancer, homogenized [OPG study]7.911379
GSM549139patient 042, cancer, homogenized [OPG study]7.9952181
GSM549099patient 107, normal, homogenized [OPG study]7.8712581
GSM549109patient 139, normal, homogenized [OPG study]8.3329784
GSM549110patient 046, normal, homogenized [OPG study]8.1631283
GSM549114patient 063, normal, homogenized [OPG study]7.8655780
GSM549122patient 082, normal, homogenized [OPG study]8.1365882
GSM549134patient 033, cancer, homogenized [OPG study]7.5217477
GSM549136patient 036, cancer, homogenized [OPG study]7.911380
GSM549140patient 044, cancer, homogenized [OPG study]7.9648380
GSM549111patient 047, normal, homogenized [OPG study]8.0224281
GSM549113patient 057, normal, homogenized [OPG study]7.6895778
GSM549132patient 031, cancer, homogenized [OPG study]8.1190482
GSM549137patient 038, cancer, homogenized [OPG study]7.8132479
GSM549142patient 047, cancer, homogenized [OPG study]9.9442396
GSM549100patient 110, normal, homogenized [OPG study]7.9885182
GSM549107patient 135, normal, homogenized [OPG study]7.8347780
GSM549115patient 068, normal, homogenized [OPG study]7.7998879
GSM549116patient 072, normal, homogenized [OPG study]7.9229880
GSM549120patient 078, normal, homogenized [OPG study]8.5655786
GSM549131patient 030, cancer, homogenized [OPG study]7.4626875
GSM549118patient 074, normal, homogenized [OPG study]8.1075582
GSM549129patient 027, cancer, homogenized [OPG study]9.1358590
GSM549123patient 088, normal, homogenized [OPG study]8.4223985
GSM549124patient 006, cancer, homogenized [OPG study]8.2545784
GSM549126patient 015, cancer, homogenized [OPG study]7.9065180
GSM549128patient 025, cancer, homogenized [OPG study]8.0701381
GSM549103patient 117, normal, homogenized [OPG study]8.4973286
GSM549117patient 073, normal, homogenized [OPG study]7.8875180
GSM549138patient 041, cancer, homogenized [OPG study]7.8297579
GSM549141patient 045, cancer, homogenized [OPG study]7.6684477
GSM549130patient 028, cancer, homogenized [OPG study]8.4658286
GSM549101patient 111, normal, homogenized [OPG study]8.1195383
GSM549105patient 128, normal, homogenized [OPG study]7.9468381
GSM549106patient 134, normal, homogenized [OPG study]7.5770876
GSM549112patient 048, normal, homogenized [OPG study]7.8903980
GSM549125patient 011, cancer, homogenized [OPG study]8.3961385
GSM549127patient 024, cancer, homogenized [OPG study]8.0155781
GSM549135patient 035, cancer, homogenized [OPG study]8.0123680